A detailed history of Empire Financial Management Company, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 38,491 shares of ABT stock, worth $4.48 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
38,491
Holding current value
$4.48 Million
% of portfolio
1.32%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $3.88 Million - $4.33 Million
38,491 New
38,491 $4 Billion
Q4 2023

Feb 15, 2024

BUY
$90.19 - $110.4 $32,919 - $40,296
365 Added 0.98%
37,436 $4.12 Billion
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $2,865 - $3,438
-30 Reduced 0.08%
37,071 $3.59 Billion
Q2 2023

Jul 27, 2023

SELL
$100.78 - $112.29 $323,403 - $360,338
-3,209 Reduced 7.96%
37,101 $4.04 Billion
Q1 2023

Apr 20, 2023

BUY
$96.86 - $114.01 $3.9 Million - $4.6 Million
40,310 New
40,310 $4.08 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Empire Financial Management Company, LLC Portfolio

Follow Empire Financial Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Financial Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empire Financial Management Company, LLC with notifications on news.